| Product Code: ETC13365181 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Pharmaceutical Anti-Counterfeiting Technologies Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Pharmaceutical Anti-Counterfeiting Technologies Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenues & Volume, 2021 & 2031F |
3.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market - Industry Life Cycle |
3.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market - Porter's Five Forces |
3.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenues & Volume Share, By Authentication Method, 2021 & 2031F |
3.9 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenues & Volume Share, By Material Used, 2021 & 2031F |
3.10 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Pharmaceutical Anti-Counterfeiting Technologies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Pharmaceutical Anti-Counterfeiting Technologies Market Trends |
6 North America Pharmaceutical Anti-Counterfeiting Technologies Market, 2021 - 2031 |
6.1 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By RFID & NFC, 2021 - 2031 |
6.1.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Tamper-Evident Packaging, 2021 - 2031 |
6.1.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Blockchain-Based Solutions, 2021 - 2031 |
6.1.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Serialization & Barcoding, 2020 - 2028 |
6.1.6 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Chemical Taggants, 2020 - 2028 |
6.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Track & Trace, 2021 - 2031 |
6.2.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Supply Chain Security, 2021 - 2031 |
6.2.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Data Integrity, 2021 - 2031 |
6.2.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Drug Authentication, 2021 - 2031 |
6.2.6 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Anti-Tampering, 2020 - 2028 |
6.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Authentication Method, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Digital Verification, 2021 - 2031 |
6.3.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Holograms, 2021 - 2031 |
6.3.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By QR Codes, 2021 - 2031 |
6.3.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Serialization Codes, 2021 - 2031 |
6.3.6 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Spectroscopic Markers, 2021 - 2031 |
6.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Material Used, 2021 - 2031 |
6.4.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Polymer Films, 2021 - 2031 |
6.4.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Paper & Board, 2021 - 2031 |
6.4.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Security Inks, 2020 - 2028 |
6.4.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Tamper-Resistant Labels, 2020 - 2028 |
6.4.6 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Microprinting, 2020 - 2028 |
6.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By End User, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Drug Manufacturers, 2020 - 2028 |
6.5.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Distributors, 2020 - 2028 |
6.5.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Retail Pharmacies, 2020 - 2028 |
6.5.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Hospitals & Clinics, 2020 - 2028 |
6.5.6 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Regulatory Authorities, 2020 - 2028 |
7 North America Pharmaceutical Anti-Counterfeiting Technologies Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.1 United States (US) Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.2 Canada Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.3 Rest of North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Authentication Method, 2021 - 2031 |
7.4.1 United States (US) Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Authentication Method, 2021 - 2031 |
7.4.2 Canada Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Authentication Method, 2021 - 2031 |
7.4.3 Rest of North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Authentication Method, 2021 - 2031 |
7.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Material Used, 2021 - 2031 |
7.5.1 United States (US) Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Material Used, 2021 - 2031 |
7.5.2 Canada Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Material Used, 2021 - 2031 |
7.5.3 Rest of North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By Material Used, 2021 - 2031 |
7.6 North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 United States (US) Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Canada Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Rest of North America Pharmaceutical Anti-Counterfeiting Technologies Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Pharmaceutical Anti-Counterfeiting Technologies Market Key Performance Indicators |
9 North America Pharmaceutical Anti-Counterfeiting Technologies Market - Export/Import By Countries Assessment |
10 North America Pharmaceutical Anti-Counterfeiting Technologies Market - Opportunity Assessment |
10.1 North America Pharmaceutical Anti-Counterfeiting Technologies Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.3 North America Pharmaceutical Anti-Counterfeiting Technologies Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America Pharmaceutical Anti-Counterfeiting Technologies Market Opportunity Assessment, By Authentication Method, 2021 & 2031F |
10.5 North America Pharmaceutical Anti-Counterfeiting Technologies Market Opportunity Assessment, By Material Used, 2021 & 2031F |
10.6 North America Pharmaceutical Anti-Counterfeiting Technologies Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Pharmaceutical Anti-Counterfeiting Technologies Market - Competitive Landscape |
11.1 North America Pharmaceutical Anti-Counterfeiting Technologies Market Revenue Share, By Companies, 2022 |
11.2 North America Pharmaceutical Anti-Counterfeiting Technologies Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here